Journal article
Survival Benefit of Adjuvant Brachytherapy After Hysterectomy With Positive Surgical Margins in Cervical Cancer
International journal of radiation oncology, biology, physics, v 102(2), pp 373-382
01 Oct 2018
PMID: 29890264
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
We evaluated the use of brachytherapy (BT) in addition to external beam radiation therapy (EBRT) and the resulting effect on survival in patients with cervical cancer after hysterectomy with positive surgical margins.
Patients with cervical cancer diagnosed from 2004 to 2015 who underwent hysterectomy followed by adjuvant EBRT were identified using the National Cancer Database. Only patients with positive surgical margins were included for analysis. Logistic regression was used to evaluate predictors of BT use and for propensity score matching. Survival was compared between patients receiving EBRT alone and those receiving EBRT combined with BT for adjuvant treatment. Survival analysis using log-rank test and Cox proportional hazards modeling was performed in the overall and propensity score-matched cohorts.
We identified 1719 patients who underwent hysterectomy with positive surgical margins followed by adjuvant radiation therapy, of whom 778 (45.3%) received additional BT. Predictors of increased receipt of BT included age >55 years, private rather than government insurance, radiation treatment duration ≥7 weeks, EBRT dose ≥4500 cGy, and time between radiation and surgery ≤9 weeks. With a median follow-up of 3.8 years, 3-year overall survival was 79.4% in patients receiving BT compared with 71.9% in patients receiving EBRT alone (log-rank P < .001). On multivariate analysis, EBRT and BT were associated with significantly improved survival (hazard ratio 0.77; 95% confidence interval 0.64-0.92; P = .003) compared with EBRT alone. The survival benefit of combining EBRT and BT persisted on propensity score-matched analysis (log-rank P = .005).
In women with positive margins after hysterectomy for cervical cancer, the combination of EBRT and BT showed significantly improved overall survival compared with EBRT alone. However, only 45.3% of patients in our cohort received BT.
Metrics
Details
- Title
- Survival Benefit of Adjuvant Brachytherapy After Hysterectomy With Positive Surgical Margins in Cervical Cancer
- Creators
- Richard Li - City Of Hope National Medical CenterAshwin Shinde - City Of Hope National Medical CenterYi-Jen Chen - Department of Radiation Oncology, City of Hope Medical Center, Duarte, CaliforniaArya Amini - City Of Hope National Medical CenterStephen Lee - City Of Hope National Medical CenterThanh Dellinger - City Of Hope National Medical CenterErnest Han - City Of Hope National Medical CenterMark Wakabayashi - City Of Hope National Medical CenterRebecca Nelson - City Of Hope National Medical CenterSushil Beriwal - UPMC Hillman Cancer CenterScott Glaser - City Of Hope National Medical Center
- Publication Details
- International journal of radiation oncology, biology, physics, v 102(2), pp 373-382
- Publisher
- Elsevier
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- Radiation Oncology (and Nuclear Medicine)
- Web of Science ID
- WOS:000443180100020
- Scopus ID
- 2-s2.0-85052203305
- Other Identifier
- 991021897275604721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Collaboration types
- Domestic collaboration
- Web of Science research areas
- Oncology
- Radiology, Nuclear Medicine & Medical Imaging